Cancer Vaccines 2025, Part II: The Rise of DNA Cancer Vaccines | Cromos Pharma
Cancer Vaccines 2025, Part II: The Rise of DNA Cancer Vaccines Cancer vaccines are entering a new era — and it’s no longer just about mRNA. A powerful second wave is gaining momentum: DNA cancer vaccines. Read more
cancer vaccines
Cancer Vaccines 2025, Part I: The mRNA Revolution The race to develop cancer vaccines is accelerating. Fueled by decades of research, mRNA platforms have emerged as a leading modality in oncology, delivering early clinical signals across multiple tumor types. This article kicks off our multi-part series on the evolving landscape of cancer vaccines. We begin with therapeutic mRNA vaccines, the most clinically advanced Read more
Cover image illustrating key innovations in Alzheimer’s research and care in 2025.
Five Insights Changing Alzheimer’s Care in 2025 Today, an estimated 57 million people are living with dementia, and around 60–70% of them have Alzheimer’s disease, the most common and devastating form of cognitive decline. In the U.S., Alzheimer’s has climbed to the sixth leading cause of death, surpassing breast and prostate cancers combined. And the challenge is only growing: by 2050, the Read more
Clinical Research Focus. 46th Edition Nobel Laureate Unveils Technique to Turn Rogue T Cells into Their Own Treatment Just weeks after receiving the 2025 Nobel Prize for discovering regulatory T cells, Shimon Sakaguchi and colleagues have published two Science Translational Medicine papers showing how disease-causing T cells can be reprogrammed into regulatory ones. The approach suppressed inflammation and autoimmune reactions Read more

Schedule a meeting

We are excited to connect with you, understand your goals, and explore how we can support your needs.

Contact us